Skip to main content

The FDA Just Approved the First Generic Naloxone Nasal Spray | Time

By April 22, 2019News
emergent-biosolution-logo

emergent-biosolution-logo

The Food and Drug Administration (FDA) on Friday announced that it granted final approval to the first generic naloxone hydrochloride nasal spray, which can be used to reverse opioid overdoses.

{iframe}http://time.com/5574107/fda-generic-naloxone-nasal-spray/{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.